1
prepared by mixing the stock aqueous buffer with methanol in a 7 :
3 (v/v) ratio. The CSW 1.7 (Data Apex, Prague, Czech Republic)
data station served for the measurement of migration times of
detected zones and for calculation of peak characteristics common
in chromatography. Migration times were converted to mobilites
given in 10−9 m2 V−1 s−1 units using the definition equation given
elsewhere.2
3H). 11B-NMR (CD3COCD3): d −2.0 (d, JBH = 196, 1B), −2.9
(d, 1JBH = 144, 1B), −7.6 (d, 1JBH = 172, 2B), −9.1 (2B), −9.8 (d,
1JBH = 132, 4B). 13C{ H}-NMR (CD3COCD3): d 148.8 (s, C2pyr),
1
148.1 (s, C6pyr), 139.1 (s, C4pyr), 125.5 (s, C3pyr), 124.9 (s, C5pyr), 87.51
(s, Cc–Py), 85.2 (s, Cc–SEt), 30.0 (s, CCH2), 11.9 (s, CCH3).
Synthesis of 1-(2ꢀ-pyridyl)-2-SiPr-1,2-closo-C2B10H10 (3)
In the same manner as for compound 2, to a solution of KOH
(6 mg, 0.11 mmol) in deoxygenated ethanol (5 ml), was added (1-
(2ꢀ-pyridyl)-2-SH-1,2-closo-C2B10H10) (28 mg, 0.11 mmol). After
stirring for 1 h at room temperature the solvent was evaporated
and the residue redissolved in dry THF (5 ml). Bromoisopropyl
(0.02 ml, 0.22 mmol) was added and the mixture was refluxed
for 2 h. All volatiles were evaporated under vacuum, and the
residue was treated with diethyl ether (10 ml) and water (10 ml),
the organic layer was separated and washed with KOH (3 ×
10 ml, 0.5 M), dried over anhydrous MgSO4 and evaporated under
vacuum resulting a yellow oil. Yield: 29 mg (81%). Anal. calcd for
C10H21B9NS: N, 4.92; C, 42.20; H, 7.44; S, 11.27. Found: N, 4.64;
C, 42.2; H, 7.70; S, 10.91%. IR: m/cm−1 2932 (Caryl–H/Calkyl–H);
2577 (B–H); 2352, 2361 (S–R); 1464, 1434 (C–N); 1081, 1012 (C–
Synthesis of 1-(2ꢀ-pyridyl)-1,2-closo-C2B10H11 (1)
This compound synthesis was first reported by Wade et al.10a,25 The
synthetic procedure described here is different to the one reported.
A total of 0.747 g (6 mmol) of decaborane and 1.56 ml of
dimethylaniline dissolved in 20 ml of toluene was refluxed for 2 h
under nitrogen. After cooling, 0.41 ml (4 mmol) of ethynylpiridine,
was added and the reaction mixture was heated under reflux for
18 h more. The solvents were removed under vacuum, and the
residue was treated with 5 ml of methanol for 30 min under stirring.
Upon evaporation of the solvent, the product was treated with
◦
petroleum ether (boiling range = 35–70 C). The insoluble solid
was sublimed and the petroleum ether was evaporated to dryness
to afford in total 0.36 g (1.6 mmol) of 1 (40%). Anal. calcd for
C7H15B10N: N, 6.33; C, 37.99; H, 6.83; S, 11.4; Found: N, 6.08; C,
11
N–C). 1H{ B}-NMR (CDCl3): d 8.65 (d, 3JHH = 4.5, Cpyr–H, 1H),
4
38.57; H, 6.82%. IR: m/cm−1 3067 (Caryl–H); 2958, 2924, 2854 (Caryl
–
7.75 (m, Cpyr–H, 2H), 7.39 (ddd, 3JHH = 5.3, JHH = 1.8, Cpyr–H,
1H), 3.25 (h, 3JHH = 6.9, CH, 1H), 2.95 (s, B–H, 2H), 2.57 (s, B–H,
=
H); 2643, 2631, 2605, 2590, 2567 (B–H); 1574 (C N); 1464, 1434
11
3
(C–N); 1019, 1011 (C–N–C). 1H{ B}-NMR (CD3COCD3): d 8.51
2H), 2.47 (s, B–H, 4H), 2.27 (s, B–H, 2H), 1.12 (d, JHH = 6.9,
1
(d, 3JHH = 4.4, Cpyr–H6, 1H), 7.92 (td, 3JHH = 7.8, 4J(H,H) = 1.6
CH3, 6H). 11B-NMR (CDCl3): d −2.4 (d, JBH = 156, 1B), −3.6
1
1
1
Cpyr–H4, 1H), 7.71 (d, 3JHH = 7.8, Cpyr–H3, 1H), 7.51 (ddd, 3JHH
=
(d, JBH = 138, 1B), −8.5 (d, JBH = 159, 2B), −10.4 (d, JBH
=
7.8, 4JHH = 4.4, 5JHH = 0.6, Cpyr–H5, 1H), 5.42 (s, Cc–H, 1H), 2.49
126, 6B). 13C{ H}-NMR (CDCl3): d 149.1 (s, Cpyr), 136.9 (s, Cpyr),
126.1 (s, Cpyr), 124.7 (s, Cpyr), 121.5 (s, Cpyr), 87.5 (s, Cc–pyr), 85.7
(s, Cc–SiPr), 42.6 (s, S–CH), 23.8 (s, CH–CH3).
1
(s, B–H), 2.35 (s, B–H), 2.27 (s, B–H). 11B-NMR (CD3COCD3): d
−2.7 (d, 1JBH = 152, 1B), −3.5 (d, 1JBH = 150, 1B), −7.9 (d, 1JBH
=
=
153, 2B), −9.8 (d, 2B), −10.5 (d, 1JBH = 167, 2B), −12.4 (d, 1JBH
1
158, 2B). 13C{ H}-NMR (CDCl3): d 148.8 (s, C2pyr), 152.0 (s, C2pyr),
150.6 (s, C6pyr), 139.6 (s, C4pyr), 126.4 (s, C3pyr), 123.1 (s, C5pyr), 77.6
(s, Cc–Py), 59.6 (s, Cc–H).
Synthesis of [NMe4][7-(2ꢀ-pyridyl)-8-SEt-7,8-nido-C2B9H10],
[NMe4][4]
To a Schlenk flask containing a solution of KOH (70 mg, 1.2 mmol)
in deoxygenated ethanol (5 ml), was added 1-(2ꢀ-pyridyl)-2-SEt-
1,2-closo-C2B10H10 (71 mg, 0.25 mmol). The mixture was refluxed
for 3 h, cooled to room temperature and the solvent evaporated.
The residue was dissolved in water (2 ml) and treated with a
solution of tetramethylammonium chloride. The white solid was
filtered off and washed with water and diethyl ether. Yield: 61 mg,
0.17 mmol (70%). Anal. calcd for C13H31B9N2S: N, 8.13; C, 45.29;
H, 9.06; S, 9.30. Found: N, 8.01; C, 45.41; H,9.17, S, 9.51%. IR:
Synthesis of 1-(2ꢀ-pyridyl)-2-SEt-1,2-closo-C2B10H10 (2)
To a two necked round bottom flask (50 ml), containing a solution
of KOH (25 mg, 0.45 mmol) in deoxygenated ethanol (10 ml),
was added (1-(2ꢀ-pyridyl)-2-SH-1,2-closo-C2B10H10) (115 mg,
0.45 mmol). After stirring for 1 h at room temperature the solvent
was evaporated and the residue redissolved in dry THF (10 ml).
Bromoethane (0.013 ml, 0.90 mmol) was added and the mixture
was refluxed for 2 h. All volatiles were evaporated under vacuum,
and the residue was treated with diethyl ether (10 ml) and water
10 ml, the organic layer was separated and washed with KOH
(3 × 10 ml, 0.5 M), dried over anhydrous MgSO4 and evaporated
under vacuum resulting a yellow solid. Yield: 112 mg (88%). Anal.
calcd for C9H19B10NS: N, 4.97; C, 38.41; H, 6.8; S, 11.4; Found: N,
m/cm−1 2937 (Caryl–H); 2534 (B–H), 2362, (S–R); 1472 (C–N); 1026
11
(C–N–C). 1H-{ B}NMR (CD3COCD3): d 8.37 (d, 3JHH = 4, Cpyr
–
=
H, 1H), 7.48 (t, 3JHH = 8, 4JHH = 2, Cpyr–H, 1H), 7.26 (d, 3JHH
3
4
8, Cpyr–H, 1H), 7.00 (t, JHH = 6, JHH = 2, Cpyr–H, 1H), 3.44 (s,
N(CH3)4, 12H), 2.92 (q, 3JHH = 7.5, CH2–CH3, 1H), 2.65 (q, 3JHH
=
7.5, CH2–CH3, 1H), 2.47 (s, B–H, 1H), 2.23 (s, B–H, 1H), 2.20 (s,
B–H, 1H), 1.73 (s, B–H, 2H), 1.48 (s, B–H, 1H), 1.38 (s, B–H, 1H),
0.83 (t, 3JHH = 7.5, CH2–CH3, 3H), 0.73 (s, B–H, 1H), 0.24 (s, B–
H, 1H), −2.05 (s, BHB, 1H). 11B-NMR (CD3COCD3): d −7.1 (d,
1JBH = 138, 2B), −12.1 (d, 1JBH = 158, 1B), −15.9 (d, 1JBH = 142,
3B), −18.48 (d, 1JBH = 145, 1B), −32.6 (dd, 1JBH = 132, 1JBH = 29,
4.95; C, 38.20; H, 6.50; S, 11.15%. IR: m/cm−1 2965, 2924 (Caryl
–
=
H/Calkyl–H); 2569 (B–H); 2364, 2338 (S–R); 1584 (C N); 1463,
1433 (C–N); 1081, 1014 (C–N–C); 811 (CH3); 774, 740 (Caryl–H).
11
1H{ B}-NMR (CD3COCD3): d 8.67 (d, 3JHH = 4.7, Cpyr–H6, 1H),
3
4
5
7.95 (ddd, JHH = 7.6, J(H,H) = 7.7, JHH = 1.5, Cpyr–H4, 1H),
7.89 (ddd, 3JHH = 7.7, 4JHH = 4.7, Cpyr–H5, 1H), 7.5 (ddd, 3JHH
=
B(10)), −35.1 (d, 1JBH = 138, B(1)). 13C{ H}-NMR (CD3COCD3):
1
7.2, 4JHH = 4.6, 5JHH = 0.6, Cpyr–H3, 1H), 2.77 (q, 3JHH = 7.5, S–
CH2CH3, 2H), 3.00 (s, B–H, 1H), 2.53 (s, B–H, 1H), 2.45 (s, B–H,
4H), 2.37 (s, B–H, 2H), 2.22 (s, B–H, 2H), 0.90 (t, 3JHH = 7.5, CH3,
d 155.9 (s, Cpy), 147.4 (s, Cpyr), 135.2 (s, C4pyr), 125.2 (s, C3pyr), 120.4
(s, C5pyr), 62.7 (s, Cc), 55.1 (s, N(CH3)4), 22.2 (s, CH2), 13.4 (s, CH3).
MALDI-TOF-MS: 270.36 (47.5%, M), 208.27 (100%, M − SEt).
This journal is
The Royal Society of Chemistry 2008
Dalton Trans., 2008, 345–354 | 351
©